DE FRANCESCHI, Lucia
 Distribuzione geografica
Continente #
NA - Nord America 13.880
EU - Europa 12.814
AS - Asia 9.071
SA - Sud America 1.296
Continente sconosciuto - Info sul continente non disponibili 300
AF - Africa 275
OC - Oceania 29
Totale 37.665
Nazione #
US - Stati Uniti d'America 13.554
RU - Federazione Russa 4.247
GB - Regno Unito 3.974
SG - Singapore 3.645
CN - Cina 2.498
IT - Italia 1.123
BR - Brasile 1.016
VN - Vietnam 964
HK - Hong Kong 786
SE - Svezia 663
FR - Francia 633
DE - Germania 601
IE - Irlanda 497
FI - Finlandia 486
KR - Corea 264
UA - Ucraina 179
CA - Canada 162
ID - Indonesia 157
IN - India 136
BD - Bangladesh 121
AR - Argentina 103
JP - Giappone 97
MX - Messico 85
TR - Turchia 84
NL - Olanda 76
NG - Nigeria 64
AT - Austria 63
PL - Polonia 54
PK - Pakistan 47
EC - Ecuador 46
ES - Italia 43
IQ - Iraq 43
BE - Belgio 41
ZA - Sudafrica 39
CO - Colombia 37
EG - Egitto 32
VE - Venezuela 26
AU - Australia 24
MA - Marocco 24
JM - Giamaica 22
TG - Togo 22
PY - Paraguay 21
CL - Cile 19
MY - Malesia 19
PH - Filippine 19
BJ - Benin 18
DZ - Algeria 18
LT - Lituania 18
IR - Iran 17
UZ - Uzbekistan 17
OM - Oman 16
SA - Arabia Saudita 16
GR - Grecia 15
PE - Perù 15
CZ - Repubblica Ceca 13
JO - Giordania 13
NP - Nepal 13
TW - Taiwan 13
RO - Romania 12
KE - Kenya 11
KZ - Kazakistan 11
IL - Israele 10
AZ - Azerbaigian 9
CH - Svizzera 9
CR - Costa Rica 8
GH - Ghana 8
HN - Honduras 8
HU - Ungheria 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
DK - Danimarca 7
DO - Repubblica Dominicana 7
EE - Estonia 7
KG - Kirghizistan 7
LK - Sri Lanka 7
PR - Porto Rico 7
TN - Tunisia 7
UY - Uruguay 7
LB - Libano 6
PA - Panama 6
BO - Bolivia 5
ET - Etiopia 5
LV - Lettonia 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
EU - Europa 4
GM - Gambi 4
HR - Croazia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
RS - Serbia 4
AL - Albania 3
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
KH - Cambogia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
Totale 37.314
Città #
Southend 3.580
Singapore 1.964
Ashburn 1.705
Moscow 1.379
San Jose 1.296
Jacksonville 1.252
Chandler 1.152
Dallas 930
Hong Kong 771
Woodbridge 665
Dublin 494
Verona 480
Ann Arbor 468
Council Bluffs 457
Houston 384
The Dalles 374
Beijing 363
New York 278
Ho Chi Minh City 251
Wilmington 245
Lawrence 215
Princeton 214
Los Angeles 198
Jinan 191
Dong Ket 179
Nanjing 178
Hanoi 156
Shenyang 145
Santa Clara 122
Jakarta 118
Buffalo 115
São Paulo 112
Hebei 109
Sindelfingen 108
Helsinki 104
Boardman 92
Milan 91
Munich 90
Tokyo 89
Tianjin 83
Redondo Beach 77
Ningbo 74
Nanchang 70
Zhengzhou 68
Columbus 67
Changsha 63
Seattle 62
Guangzhou 60
Hangzhou 59
Lancaster 56
Orem 56
London 55
Abuja 53
Haikou 53
Montreal 50
Nuremberg 50
Turku 49
Vienna 46
Phoenix 44
Toronto 44
Taizhou 42
Falls Church 41
Rome 41
Warsaw 40
Atlanta 39
Brooklyn 39
Brussels 37
Frankfurt am Main 37
Taiyuan 37
Lappeenranta 36
Jiaxing 35
Chicago 34
Denver 31
Rio de Janeiro 31
San Francisco 31
Annandale 29
Haiphong 29
Washington 29
Las Vegas 28
Da Nang 27
Collegeville 26
Belo Horizonte 25
Fuzhou 25
Mexico City 25
Chennai 24
Amsterdam 23
Bologna 23
Redwood City 23
Baghdad 22
Campinas 22
Falkenstein 22
Lanzhou 22
Lomé 22
Norwalk 22
Seoul 22
Stockholm 21
Boston 20
Philadelphia 20
Redmond 20
Birmingham 18
Totale 23.493
Nome #
EHA Roadmap for European Hematology Research. The European Hematology Association Roadmap for European Hematology Research: a consensus document. 602
The European Hematology Association Roadmap for European Hematology Research: a consensus document 602
Access to emergency department for acute events and identification of sickle cell disease in refugees. 435
Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease 302
Impaired pro‐resolving mechanisms promote abnormal NETosis , fueling autoimmunity in sickle cell disease 283
Mouse K-Cl cotransporte KCC1: cloning, mapping, pathological expression and functional regulation. 266
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19 265
Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H 262
Blood smear, a key diagnostic tool in hematology: Lessons from two cases of acute hemolysis in previously undiagnosed g6pd deficiency 254
Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesis. 250
A pilot study on the efficacy of ketorolac plus tramadol infusion in management of sickle cell pain combined with erythrocytopheresis in treatment of acute severe vaso-occlusive crisis 243
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 241
Two-photon microscopy imaging of thy1GFP-M transgenic mice: a novel animal model to investigate brain dendritic cell subsets in vivo 236
Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-MTHF and vitamin B12 supplementation: a single arm trial 232
A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis 228
Establised and experimental treatments for sickle cell disease 227
A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract 223
Abnormal modulation of cell protective systems in response to ischemic/reperfusion injury is important in the development of mouse sickle cell hepatopathy 223
TREATMENT OF SKELETAL DISEASES WITH A NATURALLY DERIVED ANTIOXIDANT AND BISPHOSPHONATE EMBEDDED NANOPARTICLES 223
A Selective Oral GLYT1 Inhibitor, Improves Anemia and Red Cell Survival in a Mouse Model of Beta-Thalassemia 222
Resveratrol Induces Erythroid Maturation by Activating FOXO3 and Improves in Vivo Erythropoiesis in Normal and Beta -Thalassemic Mice 216
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 216
Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis 215
Climate change, air pollution, and increase of respiratory allergies: just a coincidence or something more? 212
A mutation in the iron responsive element of ferritin L-subunit gene is associated with the recently described ''hereditary hyperferritinemia-cataract syndrome''. 211
Fentanyl buccal tablet: a new breakthrough pain medication in early management of severe vaso-occlusive crisis in sickle cell disease. 209
A Rare Disorder in an Orphan Disease: Kikuchi Fujimoto Disease in a Young-Adult Patient with Sickle Cell Anemia 207
Protease inhibitors-based therapy induces acquired spherocytic-like anemia and ineffective erythropoiesis in chronic HCV patients 206
Analisi proteomica del siero di pazienti reumatici affetti da sclerodermia e di pazienti ematologici sottoposti a trapianto con midollo che hanno sviluppato un rigetto scleroderma-like. 205
Computational identification of phospho-tyrosine sub-networks related to acanthocyte generation in neuroacanthocytosis. 204
Oxidative damage and erythrocyte membrane transport abnormalities in thalassemias 203
K-Cl cotransport (KCC) plays an important role in normal and b thalassemic erythropoiesis 200
Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band3 200
The interplay between peroxiredoxin-2 and Nrf2 is important in limiting oxidative mediated dysfunction in b-thalassemic erythropoiesis 197
New Therapeutic Options for the Treatment of Sickle Cell Disease. 197
K-Cl cotransport modulation by intracellular Mgh in erythrocytes from mic bred for low and high Mg levels 194
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 194
Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity 192
Peroxiredoxin-2: A Novel Factor Involved in Iron Homeostasis 192
MODULATORS OF PROTEIN TYROSINE PHOSPHATASE AND USES THEREOF 191
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis. 191
NCOA4 Deficiency Impairs Systemic Iron Homeostasis 190
A novel erythroi anion exchange variant (Gly796Arg) of hereditary stomatocytosis associated with dyserythropoiesis 189
Heat shock protein-27, 70 and peroxiredoxin-II show molecular chaperone function in sickle red cells: evidences from transgenic sickle cell mouse model 189
Factor H interfers with the adhesion of sickle red cells to vascular endothelium: a novel disease modulating molecule 188
Acute haemolysis by cold antibody during SARS-CoV-2 infection in a patient with Evans syndrome: a case report and literature review 188
Oxidative stress and b-thalasssemic erythroid cells behind the molecular defect 186
The Local Complement Activation on Vascular Bed of Patients with Systemic Sclerosis: A Hypothesis-Generating Study 185
IN ChAc RED CELLS THE ABNORMALLY ACTIVATED LYN AFFECTS ANKYRIN MULTIPROTEIN COMPLEXES AND IS INHIBITED BY DASATINIB 185
Band 3 Erythrocyte Membrane Protein Acts as Redox Stress Sensor Leading to Its Phosphorylation by p (72) Syk 185
Abnormal red cell structure and function in neuroacanthocytosis 183
Erythrocyte membrane anion exchange abnormalities in Chorea-acantocytosis:the band 3 network 179
Therapeutic targeting of Lyn kinase to treat chorea-acanthocytosis 178
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 177
Endothelin receptorantagonism prevents vaso-occlusion induced hemodynamic changes, reduces renal and lung damage and abrogates hypoxia-induced mortality in experimental sickle cell disease 177
Dietary w-3 fatty acids protect against vasculopathy in a transgenic mouse model for sickle cell disease. 177
Neuronal Dysfunction in iPSC-Derived Medium Spiny Neurons from Chorea-Acanthocytosis Patients Is Reversed by Src Kinase Inhibition and F-Actin Stabilization 177
A new therapeutic approach for sickle cell disease. Blockade of the red cell Ca(2+)-activated K+ channel by clotrimazole 176
Oxidative stress modulates heme levels and induces peroxiredoxin-2 in β thalassemic erythropoiesis as novel cytoprotective response 176
Might Helicobacter pylori infection be associated with distortion on taste perception? 176
The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with beta thalassemia intermedia 175
Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice 175
Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome 175
Acrylamide-agarose copolymers: improved resolution of high molecular-mass proteins in 2D electrophoresis 174
Deoxygenation affects tyrosine phosphoproteome of red cell membrane from patients with sickle cell disease 174
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 174
Abnormal red cells features associated with hereditary neurodegenerative disorders: the neuroacanthocytosis syndromes. 172
An unusual case of sarcoidosis in an adult patient with sickle cell disease: Management with methotrexate and low dose of steroid 170
Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment? 169
Ca(2+)-activated K+ transport in erythrocytes. Comparison of binding and transport inhibition by scorpion toxins 168
Use of divalent cations for inhibiting erythrocyte dehydration in vivo 168
Can 5-methylentetrahydrofolate modify the phospholipid fatty acid pattern in cystic fibrosis pediatric patients? 167
Analysis of functional and post-translational modifications in abnormal red cells from neuroacanthocytosis 167
Sickle cell disease and hyperreactive malarial splenomegaly (HMS) in young immigrants from Africa. 166
Development of Algorithm for Clinical Management of Sickle Cell Bone Disease: Evidence for a Role of Vertebral Fractures in Patient Follow-up 165
The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model 162
Membrane oxidative damage causes hemolitic anemia during ribavirin therapy for chronic hepatitis C 160
Increased levels of ERFE-encoding FAM132B in patients with congenital dyserythropoietic anemia type II 159
Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension 158
Functional and proteomic analysis of red cells from chorea-acanthocytosis patients 158
Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: A mutation in the iron-responsive element of ferritin L-subunit gene 156
Proteomic and functional analysis of tyrosinephosphorylated red cell membrane proteins in mouse lacking SRC-family-kinases 156
Dietary ω-3 fatty acid supplementation improves murine sickle cell bone disease and reprograms adipogenesis 155
Low‑dose anti‑IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance 155
PTPε has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells 153
Adaptative Up-Regulation of PRX2 and PRX5 Expression Characterizes Brain from a Mouse Model of Chorea-Acanthocytosis 152
Pharmacological inhibition of calpain-1 prevents red cell dehydration and reduces Gardos channel activity in a mouse model of sickle cell disease 152
Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury. 152
Role of membrane oxidative damage in the pathogenesis of hemolitic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection 151
Oxidative stress modulates heme synthesis and induces peroxiredoxin-2 as a novel cytoprotective response in β-thalassemic erythropoiesis 151
The novel role of peroxiredoxin-2 in red cell membrane protein homeostasis and senescence. 151
Access to emergency departments for acute events and identification of sickle cell disease in refugees 151
Effects of hypoxia–reoxygenation stimuli on renal redox status and nuclear factor erythroid 2-related factor 2 pathway in sickle cell SADmice 150
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 149
Dignosis and initial treatment of acute events in sikle cell disease 148
Red blood cell cation transport in uremic anemia:evidence for an increase K/CL cotransport activity 148
Tyrosine phosphorylation modulates peroxiredoxin-2 activity in normal and diseased red cells 148
Potassium loss and cellular dehydration of stored erythrocytes following incubation in autologous plasma: role of the KCl cotransport system 147
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension 147
Clinical management of iron deficiency anemia in adults: Systemic review on advances in diagnosis and treatment 146
Totale 19.906
Categoria #
all - tutte 123.437
article - articoli 106.392
book - libri 0
conference - conferenze 14.141
curatela - curatele 0
other - altro 0
patent - brevetti 1.287
selected - selezionate 0
volume - volumi 1.617
Totale 246.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.099 0 0 0 133 86 64 43 93 91 46 129 414
2022/20233.607 258 332 370 591 336 826 39 213 371 108 108 55
2023/20241.970 88 167 135 217 234 263 83 130 20 64 393 176
2024/20255.154 328 296 157 912 269 203 248 259 795 314 383 990
2025/202614.039 1.023 709 1.013 2.249 3.474 946 1.410 815 1.011 767 286 336
2026/20271.877 196 408 612 661 0 0 0 0 0 0 0 0
Totale 37.665